Related Experiment Videos
Cerebellar atrophy in an epileptic child: is it due to phenytoin?
S R Ahuja1, S Karande, M V Kulkarni
1Division of Paediatric Neurology, Department of Paediatrics, LTM Medical College and Hospital, Sion, Mumbai - 400 022, India.
Insights
A child experienced cerebellar dysfunction due to high phenytoin levels from epilepsy treatment. This phenytoin toxicity caused severe cerebellar atrophy, with symptoms persisting even after discontinuing the medication.
Area of Science:
- Neurology
- Pediatrics
- Clinical Pharmacology
Background:
- Epilepsy management in children often involves anticonvulsant medications like phenytoin.
- Long-term phenytoin therapy requires careful monitoring of serum drug levels and potential toxic effects.
Observation:
- A pediatric patient on long-term phenytoin therapy presented with new-onset cerebellar dysfunction.
- Elevated serum phenytoin levels (33 mcg/ml) were detected.
- Brain imaging revealed severe, generalized cerebellar atrophy.
Findings:
- The observed cerebellar dysfunction was directly attributed to phenytoin overdose and toxicity.
- Cerebellar atrophy was a significant finding in this case.
- Neurological deficits persisted despite the cessation of phenytoin treatment.
Implications:
- This case highlights the critical need for vigilant monitoring of phenytoin levels in pediatric patients to prevent toxicity.
- It underscores the potential for severe, long-lasting cerebellar damage from phenytoin overdose.
- Clinicians should consider drug toxicity in the differential diagnosis of cerebellar dysfunction in children undergoing anticonvulsant therapy.
Abstract:
A four and half year old epileptic child on phenytoin therapy since one year presented with signs of cerebellar dysfunction. Serum phenytoin level was high (33 mcg/ml) and computerised tomographic scan of the brain showed severe generalised cerebellar atrophy. The cerebellar signs represented drug over dosage and toxicity and persisted long after omission of phenytoin.